Research on the Application and Mechanism of Low-Concentration Atropine in the Treatment of Myopia in Children and Adolescents

近些年，随着我国近视发生率的逐年上升，近视已经成为影响我国国民尤其是儿童青少年眼健康的重大公共卫生问题，近视防控也成为了国民关心的热点，大量研究表明阿托品在儿童近视防控方面有显著的临床意义，低浓度阿托品滴眼液是经过循证医学验证能够有效延缓近视进展的药物，联合其他近视防控手段对控制青少年和儿童近视进展有重要意义。In recent years, with the increasing incidence of myopia in China, myopia has become a major public health problem affecting the eye health of Chinese people, especially children and adolescents, and myopia prevention and control has also become a hot spot of national concern. A large number of studies have shown that atropine has significant clinical significance in the prevention and control of myopia in children, and low-concentration atropine eye drops are drugs that have been proven to be effective in delaying the progression of myopia, and it is of great significance to control the progression of myopia in adolescents and children in combination with other myopia prevention and control methods.